Brainstorm Secures NurOwn-associated Patents in Several Markets & BTK Inhibitors As MS Treatment?

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how Brainstorm secured Nur-Own-associated patents in several markets. Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “Could BTK Inhibitors Be the Next Big MS Treatment?”=====================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info. https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/ =====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/